Stay updated on Study of bb2121 in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Study of bb2121 in Multiple Myeloma Clinical Trial page.

Latest updates to the Study of bb2121 in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedCore content update with government operating status notice and new company/version entries; removal of an old company and older version.SummaryDifference4%
- Check19 days agoChange DetectedUpdate term from Plasma cell myeloma to Multiple myeloma and bump revision to v3.1.0 to reflect a newer version.SummaryDifference0.2%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. This change is minor and does not affect core content, pricing, stock, or time-sensitive information.SummaryDifference0.2%
- Check41 days agoChange DetectedThe web page has been updated to include information on 'Multiple myeloma' under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.5%
- Check48 days agoChange DetectedThe web page has been updated to include new information about the facility and drug details related to idecabtagene vicleucel for plasma cell myeloma, while some previous location and related topic information has been removed.SummaryDifference9%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Study of bb2121 in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of bb2121 in Multiple Myeloma Clinical Trial page.